Nosocomial infections caused by fungi have increased greatly in recent years, mainly due to
the rising number of immunocompromised patients. However, the available antifungal …

Tyrosine kinase overexpression could result in an unfavourable consequence of cancer
progression in the body. A number of kinase inhibitor drugs targeting various cancer‐related …

The rise and emergence of resistance to antifungal drugs by diverse pathogenic fungal
strains have resulted in an increase in demand for new antifungal agents. Various …

Pomegranate (Punica granatum) peels have shown numerous health benefits such as
antioxidant, anti-inflammatory, and antimicrobial activities. These health activities are owed …

Fungal infections and their increasing resistance to antibiotics are an emerging threat to
public health. Novel antifungal drugs, as well technologies that can help us bolster the …

Candida albicans is an inhabitant of mucosal surfaces in healthy individuals but also the
most common cause of fungal nosocomial blood stream infections, associated with high …

Fungal infections are a leading cause of morbidity and death for hospitalized patients,
mainly because they remain difficult to diagnose and to treat. Diseases range from …

In spite of several attempts to develop newer pharmacophores as potential antimicrobial
agents, the benzimidazole scaffold is still considered as one of the most sought after …

Breast cancer is the most common type of cancer among women and the increasing cases
of drug resistance pose a great challenge in the development of new anticancer drugs …

Increasing resistance of clinically relevant fungi is causing major problems in anti-mycotic
therapy. Particularly for immunosuppressed patients fungal infections are of concern and …